Daniel Ring, PA
Physician Assistant · Cabot, ARNPI 1669987012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 476 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,219 and has fallen 76.3% since, to $525 in 2025. Among physician assistant clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 476 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$997
- Novo Nordisk$970
- Lilly USA, LLC$816
- Amgen$788
- AstraZeneca$782
- GSK$731
- plus $3K from 34 others
What the payments were for
- Food & beverage$7,65798%
- Education$1512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,808 in reported general payments places this provider in the 95th percentile of 451 physician assistant providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 53 | $70,440 |
| OzempicSemaglutide | 63 | $60,306 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $48,400 |
| EliquisApixaban | 62 | $47,030 |
| TrulicityDulaglutide | 32 | $39,055 |
| MounjaroTirzepatide | 27 | $27,738 |
| RexultiBrexpiprazole | 15 | $24,045 |
| FarxigaDapagliflozin Propanediol | 19 | $23,160 |
| VraylarCariprazine Hcl | 14 | $20,150 |
| LinzessLinaclotide | 16 | $17,172 |
| JanuviaSitagliptin Phosphate | 12 | $13,430 |
| Repatha SureclickEvolocumab | 23 | $12,755 |
| Spiriva RespimatTiotropium Bromide | 11 | $9,750 |
| Emgality PenGalcanezumab-Gnlm | 14 | $9,300 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $406 | $80,19164 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $816 | $66,79259 claims |
| Novo NordiskOzempic | $970 | $60,30663 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $731 | $53,53279 claims |
| PfizerEliquis | $563 | $47,03062 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $782 | $38,47849 claims |
| AbbVieVraylar, Linzess | $997 | $37,32230 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $230 | $24,04515 claims |
| MerckJanuvia | $105 | $13,43012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 451 physician assistant providers in Arkansas.
Other physician assistant in Cabot
- Christina ReidCabot$5K
- Honey SchaumburgFort Smith$397K
- Adrienne EasterlingRogers$366K
- Katherine RossLittle Rock$44K
- Benton LoggainsFort Smith$39K
- Monte DouglasJacksonville$38K
- Anna StilinovicFayetteville$32K
- Timothy BookerLittle Rock$13K
- Callie PooleJonesboro$12K
- Bryce BassFort Smith$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.